• SENSEX 72,771.72
    -1,124.02 (--1.52%)
  • BANKNIFTY 54,471.65
    -1,108.75 (--1.99%)
  • NSE
    1,761.00 1,761.00(%)
  • SS Retail
    700.00 603.00(%)
  • Hero Motors
    127.67 80.50(%)
  • Kotak Mah. Bank
    395.80 345.40(%)
  • Aequs
    274.05 274.60(%)
  • Axis Bank
    1,205.00 1,125.50(%)
  • Clean Max Enviro
    1,301.00 728.00(%)
  • Reliance Industries
    1,196.05 1,196.05(%)
  • SBI
    956.30 855.90(%)
  • SBI Nifty 1D RL
    1,057.75 1,059.72(%)
  • HDFC Bank
    718.05 682.00(%)
  • Bharti Airtel
    1,763.60 1,745.00(%)
  • PB Fintech.
    1,135.40 1,115.10(%)
  • Ashok Leyland
    154.80 134.20(%)
  • Interglobe Aviat
    4,845.00 3,894.80(%)
  • ICICI AMC
    3,236.80 3,609.85(%)
  • R Systems Intl.
    282.80 446.55(%)
  • Infosys
    1,009.55 1,727.85(%)
  • Star Health Insu
    550.20 416.85(%)
  • Varun Beverages
    426.30 381.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Viyash Scientific Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 2086.0
  • ISIN : INE807F01027
241.00 -3 (-1.37%)
  • As on 28 Sep 2026 (EOD)

  • Today’s Low

    239.15

  • Today’s High

    244.35

  • Open

    244.35

  • Perv Close

    244.35

  • 52W Low

    178.13

  • 52W High

    298.00

Key Indicators

  • P/E(TTM)

    124.77

  • Mar.Cap (₹Cr.)

    10,643.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    70.14

  • Debt-Equity Ratio

    -1.37

  • AGM Date

    28-Sep-2026

  • EPS

    1.93

  • P/E Ratio

    124.77

Financials Ratios

  • Debt-Equity Ratio

    0.69

  • Mar.Cap (₹Cr.)

    10,643.23

  • RONW (%)

    -3.09

  • ROCE (%)

    0.45

Score Board

  • Equity (₹ in Cr.)

    88.33

  • BV (₹)

    70.10

  • Sales( ₹ in Cr.)

    1,382.06

  • NP (in Cr.)

    104.50

  • NP Var(%)

    15.0

  • Div%

    0.0

  • CPS (₹)

    5.20

  • EPS (₹)

    2.40

  • Traded Value (₹ in Lakhs)

    10,634.39

  • 52 Week High

    298.00

  • 52 Week Low

    178.13

  • Price BSE

    241.0

  • Price NSE

    241.00

  • Market Capital( in Cr.)

    10,634.39

  • P/C Ratio

    46.50

  • P/E Ratio

    101.90

  • Price Vs.BV

    2.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,382.06 1,310.34 168.52 222.69 219.63 265.46
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,382.06 1,310.34 168.52 222.69 219.63 265.46
Other Income 66.26 72.59 45.98 28.24 27.64 19.97
Stock Adjustments 4.36 8.61 -5.35 -19.42 19.73 15.56
Total Income 1,452.68 1,391.54 209.15 231.51 267.00 300.99
EXPENDITURE :            
Raw Materials 628.23 599.56 102.54 116.50 128.39 124.43
Power and Fuel Cost 83.50 79.28 12.89 13.93 11.96 12.77
Employee Cost 213.75 215.85 30.05 36.66 27.38 22.42
Other Manufacturing Expenses 124.79 119.71 21.26 41.54 52.53 57.73
Selling and Administration Expenses 89.84 78.94 17.86 19.49 19.40 20.27
Miscellaneous Expenses 55.98 99.18 11.49 1.52 0.45 10.68
Employee Benefit Expenses 213.75 215.85 30.05 36.66 27.38 22.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,196.10 1,192.52 196.09 229.63 240.11 248.29
Operating Profit 256.58 199.02 13.06 1.88 26.89 52.70
Interest 16.21 25.14 4.36 2.51 1.61 2.68
Gross Profit 240.37 173.88 8.70 -0.63 25.28 50.02
Depreciation 124.15 124.72 8.94 9.12 9.59 9.13
Profit Before Tax 116.22 49.16 -0.24 -9.75 15.69 40.89
Current Tax 15.21 39.69 0.46 -0.57 0.37 6.09
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 25.14 -49.01 -1.32 -3.09 0.52 2.69
Reported Net Profit 75.87 58.49 0.62 -6.08 14.80 32.11
Extraordinary Items -28.63 -32.49 -1.69 0.00 0.00 -0.75
Adjusted Net Profit 104.50 90.98 2.31 -6.08 14.80 32.86
Adjustment below Net Profit -0.97 -0.44 2.65 0.09 0.07 43.38
P & L Balance brought forward -438.92 -490.47 38.76 30.56 28.03 -47.47
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 6.49 0.00 -14.19 12.34 0.00
P & L Balance carried down -364.02 -438.92 42.03 38.76 30.56 28.03
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 25.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 1.74 2.34 0.02 -0.24 0.60 1.29
Earnings Per Share(Adj)-Unit Curr 1.74 2.34 0.02 -0.24 0.60 1.29
Book Value 70.88 116.20 43.59 42.43 41.55 41.45
Book Value(Adj)-Unit Curr 70.88 116.20 43.59 42.43 41.55 41.45

Shareholding Pattern

  • Promoter Group

    61.31%

  • Public Share Holding

    38.60%

  • Custodian

    0.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 267,840,334 267,840,334.00 267,840,334 267,840,334
Sub Total 267,840,334 61.31 267,840,334 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 13 0.00 13 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 19,668,140 4.50 19,668,140 34
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 12,783,338 2.93 12,783,338 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,613,443 0.83 3,613,443 18
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 36,064,934 8.26 36,064,934 60
2] Non Institution
Bodies Corporate 19,895,468 4.55 19,895,468 759
Clearing Members 2,307 0.00 2,307 4
Directors of their Relatives 0 0.00 0 0
Employees 786,899 0.18 786,899 72
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,681,439 1.53 6,681,439 2,794
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,700,383 0.62 2,700,383 1,899
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 34,314,427 7.85 34,314,427 69
Individuals holding nominal share capital up to Rs. 1 lakh 55,349,209 12.67 55,324,204 122,701
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 328 0.00 328 1
Others 12,827,499 2.94 12,827,499 5
Sub Total 132,557,959 30.34 132,532,954 128,304
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 412,250 0.09 412,250 1
Total Shares held by Custodians and against which Depository Receipts have been issued 412,250 0.09 412,250 1
Grand Total ( A + B + C ) 436,875,477 100.00 436,850,472 128,367

Company Background

Viyash Scientific LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Viyash Scientific Ltd
  • BSE Code : 2086.0
  • ISIN : INE807F01027

  • Incorporation Year

    1985

  • Registered Office

    301 Dosti Pinnacle 3rd Floor
    Plot E7 Road No 22 Wagle Indl, Thane,
    Maharashtra-400604

  • Telephone

    91-022-41114777

  • FAX

    91-022-41114754

  • Chairman

    Kamal K Sharma

  • Managing Director

  • Company Secretary

    YOSHITA SUSMIT VORA

  • Auditor

    SRBC & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Viyash Scientific Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Viyash Scientific 240.80 1,448.32 1,382.06 133.78 4.92
Abbott India 26,758.85 7,217.19 6,929.05 35.22 43.78
Astrazeneca Phar 6,287.50 2,304.07 2,275.58 92.67 27.86
Glaxosmi. Pharma 2,897.85 3,932.76 3,790.20 46.29 58.17
Novartis India 1,935.30 393.10 354.33 48.87 15.94
Cipla 1,388.90 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 737.60 773.53 729.81 68.55 12.51
Amrutanjan Healt 505.15 520.13 502.55 27.06 24.16
Fermenta Biotec. 477.35 474.15 450.25 22.29 18.77
Guj. Themis Bio. 397.45 168.25 165.82 106.27 18.05
Ambalal Sarabhai 39.13 19.52 3.94 72.46 6.77